我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
7
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
100.0%
暂无批准数据
- A groundbreaking study published in The New England Journal of Medicine demonstrates that ulipristal acetate, the active ingredient in ella emergency contraception, can effectively induce abortions with a 97% success rate. - Researchers administered 60mg doses of ulipristal acetate combined with misoprostol to 133 pregnant women, achieving comparable effectiveness to the FDA-approved abortion pill mifepristone. - The findings challenge current marketing claims by pharmaceutical companies that ella only prevents pregnancy and cannot terminate existing pregnancies.
